Thexa Pharma Private Limited, a active private limited company, was established on 01 November 2007 in Madgul, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24232TG2007PTC056165. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹14.00 Cr and a paid-up capital of ₹12.55 Cr.
Formerly known as Nitya Fine Chem Private Limited. It upholds a active non-compliant status. Its leadership includes Kiran Kumar Mamidala (Director), Vijaya Lakshmi Ramisetti (Director). Past directors included Subba Rao Nallamothu, Palla Sivaiah, Ravipati Shantisagar. It holds no open charges and ₹78.98 Cr settled loans. Its latest AGM occurred on 30 September 2018, with the balance sheet filed on 31 March 2018. It is based at Sy. No 40/13, Kulkulpally (V), Madgul (M),, Madgul, Telangana, 509327.
U24232TG2007PTC056165
056165
01 November 2007
₹14.00 Cr
₹12.55 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Thexa Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kiran Kumar Mamidala | Director | 11 Dec 2019 | Current |
| Vijaya Lakshmi Ramisetti | Director | 11 Dec 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Dec 2019 | Past |
| Pramod Abcsdd | Company Secretary | 01 Apr 2022 | Past |
| Pramod Abcsdd | Director | 15 Feb 2008 | Past |
| Pramod Abcsdd | Director | 02 Jul 2012 | Past |
| Pramod Abcsdd | Managing Director | 11 Dec 2019 | Past |
| Pramod Abcsdd | Director | 08 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Thexa Pharma Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 84.42% decrease. The company also saw a substantial fall in profitability, with a 1557.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 297.66%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Thexa Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹789,834,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 May 2015 | Others | ₹39.00 Cr | Satisfied |
| 25 May 2015 | Others | ₹8.45 Cr | Satisfied |
| 11 Dec 2013 | Canara Bank | ₹15.53 Cr | Satisfied |
| 30 Jun 2011 | Small Industries Development Bank Of India | ₹1.00 Cr | Satisfied |
| 03 Jun 2011 | Corporation Bank | ₹6.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Thexa Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Thexa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thexa Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 25 May 2015 via Charge ID 10574717 with Others was fully satisfied on 20 Dec 2021. was completed.
Progress on A charge registered on 25 May 2015 via Charge ID 10574722 with Others was fully satisfied on 20 Dec 2021. was documented.
The activity Kiran Kumar Mamidala was appointed as a Director was appointed as a Director on 11 Dec 2019 & has been associated with this company since 5 years 11 months . was completed.
Vijaya Lakshmi Ramisetti was appointed as a Director was appointed as a Director on 11 Dec 2019 & has been associated with this company since 5 years 11 months . was recorded as a recent event.
The activity Thexa Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records. was completed.
The activity A charge registered on 11 Dec 2013 via Charge ID 10469818 with Canara Bank was fully satisfied on 03 Jul 2018. was completed.
The CIN of Thexa Pharma Private Limited is U24232TG2007PTC056165.
Thexa Pharma Private Limited is headquartered at Sy. No 40/13, Kulkulpally (V), Madgul (M),, Madgul, Telangana, 509327.
Thexa Pharma Private Limited was incorporated on 01 November 2007.
The current directors of Thexa Pharma Private Limited are
The primary industry of Thexa Pharma Private Limited is Manufacturing.
Thexa Pharma Private Limited is unlisted.
The authorized capital of Thexa Pharma Private Limited is ₹14.00 Cr, and the paid-up capital is ₹12.55 Cr.
The compliance status of Thexa Pharma Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX